Literature DB >> 18723249

A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.

K W Garey1, T K Dao-Tran, Z D Jiang, M P Price, L O Gentry, H L Dupont.   

Abstract

Identification of a population at high risk for Clostridium difficile infection (CDI) would enable CDI prevention strategies to be designed. The purpose of this study was to create a clinical risk index that would predict those at risk for CDI. A CDI risk index was therefore developed, based on a cohort of hospital patients given broad-spectrum antibiotics, and divided into a development and validation cohort. Logistic regression equations helped identify significant predictors of CDI. A scoring algorithm for CDI risk was created using identified risk factors and collapsed to create four categories of CDI risk. The area under the receiver operating characteristic (aROC) curve was used to measure goodness-of-fit. Among 54 226 patients, 392 tested positive for C. difficile. Age 50-80 years [odds ratio (OR: 0.5; P<0.0116)], age >80 years (OR: 2.5; P<0.0001), haemodialysis (OR: 1.5; P=0.0227), non-surgical admission (OR: 2.2; P<0.0001) and increasing length of stay in the intensive care unit (OR: 2.1; P<0.0001) were significantly associated with CDI. A simple risk index using presence of significant variables was significantly associated with increasing risk for CDI in both development (OR: 3.57; P<0.001; aROC: 0.733) and validation (OR: 3.31; P<0.001; aROC: 0.712) cohorts. An OR-derived risk index did not perform as well as the simple risk index. This easily implemented risk index should allow stratification of patients into risk group categories for development of CDI and help fashion preventive strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723249     DOI: 10.1016/j.jhin.2008.06.026

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  21 in total

Review 1.  Recurrent Clostridium difficile infection and the microbiome.

Authors:  Rowena Almeida; Teklu Gerbaba; Elaine O Petrof
Journal:  J Gastroenterol       Date:  2015-07-08       Impact factor: 7.527

2.  A cohort study for derivation and validation of a clinical prediction scale for hospital-onset Clostridium difficile infection.

Authors:  Subhash Chandra; Nyan Latt; Ujjwal Jariwala; Venkataraman Palabindala; Rameet Thapa; Chidamber B Alamelumangapuram; Margarita Noel; Surendra Marur; Niraj Jani
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

3.  Predictors and outcomes of readmission for Clostridium difficile in a national sample of medicare beneficiaries.

Authors:  Courtney E Collins; M Didem Ayturk; Fred A Anderson; Heena P Santry
Journal:  J Gastrointest Surg       Date:  2014-11-19       Impact factor: 3.452

Review 4.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

Review 5.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

6.  Development and validation of a Clostridium difficile infection risk prediction model.

Authors:  Erik R Dubberke; Yan Yan; Kimberly A Reske; Anne M Butler; Joshua Doherty; Victor Pham; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

Review 7.  The Risks of Incident and Recurrent Clostridium difficile-Associated Diarrhea in Chronic Kidney Disease and End-Stage Kidney Disease Patients: A Systematic Review and Meta-Analysis.

Authors:  Parkpoom Phatharacharukul; Charat Thongprayoon; Wisit Cheungpasitporn; Peter J Edmonds; Pailin Mahaparn; Jackrapong Bruminhent
Journal:  Dig Dis Sci       Date:  2015-05-19       Impact factor: 3.199

8.  Longitudinal Investigation of Carriage Rates, Counts, and Genotypes of Toxigenic Clostridium difficile in Early Infancy.

Authors:  Hiroyuki Kubota; Hiroshi Makino; Agata Gawad; Akira Kushiro; Eiji Ishikawa; Takafumi Sakai; Takuya Akiyama; Kazunori Matsuda; Rocio Martin; Jan Knol; Kenji Oishi
Journal:  Appl Environ Microbiol       Date:  2016-09-16       Impact factor: 4.792

Review 9.  Current issues on safety of prokinetics in critically ill patients with feed intolerance.

Authors:  Nam Q Nguyen; Swee Lin Chen Yi Mei
Journal:  Ther Adv Drug Saf       Date:  2011-10

10.  Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors.

Authors:  Carolyn D Alonso; Simon F Dufresne; David B Hanna; Annie-Claude Labbé; Suzanne B Treadway; Dionissios Neofytos; Sylvie Bélanger; Carol Ann Huff; Michel Laverdière; Kieren A Marr
Journal:  Biol Blood Marrow Transplant       Date:  2013-08-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.